B
Benoit Bilanges
Researcher at Queen Mary University of London
Publications - 9
Citations - 1719
Benoit Bilanges is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: PI3K/AKT/mTOR pathway & Kinase. The author has an hindex of 6, co-authored 7 publications receiving 1502 citations. Previous affiliations of Benoit Bilanges include University College London.
Papers
More filters
Journal ArticleDOI
The emerging mechanisms of isoform-specific PI3K signalling
TL;DR: A better understanding of how the different PI3K isoforms are regulated and control signalling could uncover their roles in pathology and reveal in which disease contexts their blockade could be most beneficial.
Journal ArticleDOI
Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism
Lazaros C. Foukas,Benoit Bilanges,Lucia Bettedi,Wayne Pearce,Khaled Ali,Sara Sancho,Dominic J. Withers,Bart Vanhaesebroeck +7 more
TL;DR: It is found that chronic p110α partial inactivation in mice protects from age‐related reduction in insulin sensitivity, glucose tolerance and fat accumulation, and extends the lifespan of male mice, indicating that prolonged PI3K inhibition, as intended in human cancer treatment, might not negatively impact on organismal metabolism.
Journal ArticleDOI
Environmental Stress Affects the Activity of Metabolic and Growth Factor Signaling Networks and Induces Autophagy Markers in MCF7 Breast Cancer Cells
TL;DR: Exposure of cells to ambient conditions affects the activity of signaling networks previously implicated in metabolic and growth factor signaling, and it is observed that maintaining cells in ice modified but did not completely abolish this metabolic stress response.
Journal ArticleDOI
Class III phosphoinositide 3-kinase/VPS34 and dynamin are critical for apical endocytic recycling.
Sarah Carpentier,Francisca N'Kuli,Giuseppina Grieco,Patrick Van Der Smissen,Virginie Janssens,Hervé Emonard,Benoit Bilanges,Bart Vanhaesebroeck,Héloïse P. Gaide Chevronnay,Christophe E. Pierreux,Donatienne Tyteca,Pierre J. Courtoy +11 more
TL;DR: It is concluded that PI3K‐III is essential for endosome fission/recycling; and besides its role in endocytic entry, dynamin also supports tubulation of recycling endosomes.
Journal ArticleDOI
Killing two kinase families with one stone.
TL;DR: In this article, the authors proposed a personalized protein kinase inhibitor for cancer therapy, which has shown great promise in cancer therapy and has been shown to be effective against multiple target protein kinases.